Your browser doesn't support javascript.
loading
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial.
Di Giacomo, Anna Maria; Ascierto, Paolo A; Pilla, Lorenzo; Santinami, Mario; Ferrucci, Pier Francesco; Giannarelli, Diana; Marasco, Antonella; Rivoltini, Licia; Simeone, Ester; Nicoletti, Stefania Vl; Fonsatti, Ester; Annesi, Diego; Queirolo, Paola; Testori, Alessandro; Ridolfi, Ruggero; Parmiani, Giorgio; Maio, Michele.
Affiliation
  • Di Giacomo AM; Medical Oncology and Immunotherapy, Azienda Ospedaliera Universitaria Senese, Istituto Toscano Tumori, Siena, Italy.
Lancet Oncol ; 13(9): 879-86, 2012 Sep.
Article in En | MEDLINE | ID: mdl-22894884
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organophosphorus Compounds / Skin Neoplasms / Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Melanoma / Antibodies, Monoclonal / Nitrosourea Compounds Type of study: Diagnostic_studies / Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2012 Document type: Article Affiliation country: Italia Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organophosphorus Compounds / Skin Neoplasms / Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Melanoma / Antibodies, Monoclonal / Nitrosourea Compounds Type of study: Diagnostic_studies / Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2012 Document type: Article Affiliation country: Italia Country of publication: Reino Unido